Debiopharm Innovation Fund

Venture capital arm of Debiopharm Group

Corporate VC Active Switzerland
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$20.0M
total disclosed, rounds participated
Stages
—

About

Venture capital arm of Debiopharm Group

Portfolio · 2

Nucleai
Spatial Biology Software Platform for Precision Medicine
1 round $14.0M committed Latest: 2024-04
Yonalink
Data Management Solutions for Clinical Trials
Led ★ 1 round $6.0M committed Latest: 2022-11

Q&A

What is Debiopharm Innovation Fund's primary focus as an investor?
Debiopharm Innovation Fund operates as the venture capital arm of Debiopharm Group, indicating a strategic focus aligned with the parent company's interests.
Where is Debiopharm Innovation Fund headquartered?
Debiopharm Innovation Fund is headquartered in Switzerland.
When was Debiopharm Innovation Fund created?
Debiopharm Innovation Fund was created on February 9, 2023.
What type of investor is Debiopharm Innovation Fund?
Debiopharm Innovation Fund is classified as a corporate venture capital firm.